FATE THERAPEUTICS INC - COM (FATE)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
120 M
Holdings value Q1 2024
$879 M
Value change Q1 2024
+$213 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
154
Number of buys Q1 2024
83
Number of sells Q1 2024
-75
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
-0.001%
CUSIP
31189P102
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 120 M $879 M +$213 M $7.34 154
2023 Q4 93.9 M $351 M -$10.2 M $3.74 149
2023 Q3 95.4 M $202 M -$40.8 M $2.12 161
2023 Q2 108 M $515 M -$20.8 M $4.76 178
2023 Q1 112 M $637 M -$47.8 M $5.70 173
2022 Q4 104 M $1.05 B -$66 M $10.09 213
2022 Q3 107 M $2.4 B -$56.5 M $22.41 219
2022 Q2 109 M $2.67 B +$194 M $24.78 209
2022 Q1 101 M $3.91 B +$153 M $38.77 232
2021 Q4 96 M $5.62 B +$808 K $58.51 235
2021 Q3 95.7 M $5.67 B +$43.2 M $59.27 255
2021 Q2 93.8 M $8.13 B +$47.1 M $86.79 264
2021 Q1 93.7 M $7.73 B +$547 M $82.45 250
2020 Q4 82.4 M $7.5 B -$82.7 M $90.93 240
2020 Q3 87.5 M $3.49 B +$83.7 M $39.97 204
2020 Q2 85.5 M $2.93 B +$358 M $34.31 196
2020 Q1 75.5 M $1.68 B +$78.8 M $22.21 150
2019 Q4 72.2 M $1.41 B -$7.63 M $19.57 142
2019 Q3 72.1 M $1.12 B +$168 M $15.53 143
2019 Q2 62.2 M $1.26 B +$61.7 M $20.30 132
2019 Q1 59.5 M $1.05 B +$39.2 M $17.57 119
2018 Q4 57.3 M $736 M +$35.3 M $12.83 120
2018 Q3 54.8 M $891 M +$191 M $16.29 113
2018 Q2 43 M $488 M +$35.4 M $11.34 99
2018 Q1 39.4 M $385 M +$46.9 M $9.76 87
2017 Q4 35.3 M $214 M +$65.3 M $6.11 77
2017 Q3 25.4 M $101 M -$4.41 M $3.96 69
2017 Q2 26.6 M $86.2 M +$4.82 M $3.24 56
2017 Q1 25 M $114 M +$8.81 M $4.55 50
2016 Q4 23.1 M $57.9 M +$8.8 M $2.51 33
2016 Q3 19.5 M $60.8 M +$17.1 M $3.12 36
2016 Q2 14.1 M $23.9 M -$3.1 M $1.70 37
2016 Q1 15.8 M $28.4 M -$9.46 M $1.80 42
2015 Q4 18.6 M $62.7 M -$726 K $3.37 51
2015 Q3 18.3 M $97.8 M +$1.77 M $5.33 41
2015 Q2 18 M $116 M +$47.8 M $6.47 36
2015 Q1 10.6 M $51.9 M +$1.63 M $4.89 25
2014 Q4 10.3 M $51.7 M -$3.44 K $5.02 23
2014 Q3 10.3 M $52.6 M +$2.08 M $5.10 22
2014 Q2 9.85 M $62.4 M +$1.72 M $6.31 21
2014 Q1 9.56 M $92.8 M +$30.7 M $9.74 21